Cat.No. | Name | Information |
---|---|---|
M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
M42754 | MC-1-F2 | MC-1-F2 is a FOXC2 inhibitor that reduces epithelial-mesenchymal transition (EMT) markers in breast cancer cells. |
M42723 | α-Synuclein inhibitor 9 | α-Synuclein inhibitor 9 is an α-Synuclein inhibitor. |
M42722 | α-Synuclein 4554W | α-Synuclein 4554W is an inhibitor of α-Synuclein (aSyn) aggregation with associated toxicity. |
M42721 | NPT200-11 | NPT200-11 is a brain penetrating inhibitor of accumulation of alpha-synuclein (ASYN) misfolding and aggregation. |
M42720 | PBT434 methanesulfonate | PBT434 methanesulfonate is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. |
M42617 | TrxR1-IN-1 | TrxR1-IN-1 is a TrxR1 inhibitor (IC50: 8.8 μM). |
M42586 | Y-29794 oxalate | Y-29794 oxalate is a selective, orally active and blood-brain barrier permeable non-peptide prolyl endopeptidase inhibitor. |
M42532 | BC-05 | BC-05 is an orally active and potent inhibitor of CD13 and proteasome. |
M42447 | HPPD-IN-1 | HPPD-IN-1 is a HPPD inhibitor. |
M42433 | PROTAC HK2 Degrader-1 | PROTAC HK2 Degrader-1 is a PROTAC consisting of Lonidamine as a target protein Hexokinase 2 (HK2) inhibitor and Thalidomide as a CRBN ligand-linked PROTAC. |
M42308 | Acid Ceramidase-IN-2 | Acid Ceramidase-IN-2 is an acid ceramidase inhibitor with potentially antiproliferative and cytostatic activities. |
M42300 | Mergetpa | Mergetpa is a carboxypeptidase inhibitor used to block the conversion of kinins and B2 receptor antagonists to metabolites lacking the C-terminal arginine. |
M42291 | Forrestiacids J | Forrestiacids J is an ATP-citrate lyase (ACL) inhibitor with an IC50 of 2.6 μM. |
M42290 | Forrestiacids K | Forrestiacids K, a terpenoid isolated from Pseudotsuga forrestii, acts as an ATP-citrate lyase (ACL) inhibitor. |
M42284 | α‑Amylase-IN-1 | α Amylase-IN-1 is an α-Amylase inhibitor with an IC50 value of 0.5509 μM. |
M42276 | MK 386 | MK 386 (L-733692) is a selective 5-α-reductase I inhibitor, used for prostate cancer inhibition. |
M42271 | PU-48 | PU-48 is a potent urea transporters A (UT-A) inhibitor (IC50=0.32 μM). |
M41951 | Urotensin II-related peptide | Urotensin II-related peptide is a human urotensin II anague. |
M41950 | GSK 1562590 hydrochloride | GSK 1562590 hydrochloride is a high affinity and selective antagonist of urotensin-II receptor (UT), with pKis of 9.14-9.66 for mammalian recombinant (mouse, rat, cat, monkey, human) and native UT. |
M41949 | SUCNR1-IN-1 | SUCNR1-IN-1 is a SUCNR1 inhibitor (IC50: 88 nM for hSUCNR1). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.